Cited by 354Gut microbiota and healthCardiac Fibrosis and RemodelingCongenital heart defects research

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair

Tang, Tony W.H., Chen, Hung-Chih, Chen, Chen-Yun, Yen, Christopher Y.T., Lin, Chen-Ju, Prajnamitra, Ray P., Chen, Li-Lun, Ruan, Shu-Chian, Lin, Jen-Hao, Lin, Po-Ju, Lu, Hsueh-Han, Kuo, Chiung-Wen, Chang, Cindy M., Hall, Alexander D., Vivas, Eugenio I., Shui, Jr-Wen, Chen, Peilin, Hacker, Timothy A., Rey, Federico E., Kamp, Timothy J., Hsieh, Patrick C.H.·2019·Circulation

DOI 10.1161/circulationaha.118.035235

Open this paper in CoChat — free account

Abstract

Background: The impact of gut microbiota on the regulation of host physiology has recently garnered considerable attention, particularly in key areas such as the immune system and metabolism. These areas are also crucial for the pathophysiology of and repair after myocardial infarction (MI). However, the role of the gut microbiota in the context of MI remains to be fully elucidated. Methods: To investigate the effects of gut microbiota on cardiac repair after MI, C57BL/6J mice were treated with antibiotics 7 days before MI to deplete mouse gut microbiota. Flow cytometry was applied to examine the changes in immune cell composition in the heart. 16S rDNA sequencing was conducted as a readout for changes in gut microbial composition. Short-chain fatty acid (SCFA) species altered after antibiotic treatment were identified by high-performance liquid chromatography. Fecal reconstitution, transplantation of monocytes, or dietary SCFA or Lactobacillus probiotic supplementation was conducted to evaluate the cardioprotective effects of microbiota on the mice after MI. Results: Antibiotic-treated mice displayed drastic, dose-dependent mortality after MI. We observed an association between the gut microbiota depletion and significant reductions in the proportion of myeloid cells and SCFAs, more specifically acetate, butyrate, and propionate. Infiltration of CX3CR1+ monocytes to the peri-infarct zone after MI was also reduced, suggesting impairment of repair after MI. Accordingly, the physiological status and survival of mice were significantly improved after fecal reconstitution, transplantation of monocytes, or dietary SCFA supplementation. MI was associated with a reorganization of the gut microbial community such as a reduction in Lactobacillus. Supplementing antibiotic-treated mice with a Lactobacillus probiotic before MI restored myeloid cell proportions, yielded cardioprotective effects, and shifted the balance of SCFAs toward propionate. Conclusions: Gut microbiota–derived SCFAs play an important role in maintaining host immune composition and repair capacity after MI. This suggests that manipulation of these elements may provide opportunities to modulate pathological outcome after MI and indeed human health and disease as a whole.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.118.035235

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
Transient Regenerative Potential of the Neonatal Mouse Heart
Porrello, E. R., Mahmoud, A. I., Simpson, E., Hill, J. A., Richardson, J. A., Olson, E. N., & Sadek, H. A. (2011) · Science · doi:10.1126/science.1200708 · Cited by 2,545
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300

Flagged first, then by citations

Show all 43 references

Sorted by citations

Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Intestinal Microbiota in Cardiovascular Health and Disease
Tang, W. H. W., Bäckhed, F., Landmesser, U., & Hazen, S. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.024 · Cited by 524
Health Benefits and Side Effects of Short-Chain Fatty Acids
Xiong, R.-G., Zhou, D.-D., Wu, S.-X., Huang, S., Saimaiti, A., Yang, Z., Shang, A., Zhao, C., Gan, R., & Li, H. (2022) · Foods · doi:10.3390/foods11182863 · Cited by 507
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
Trøseid, M., Andersen, G. Ø., Broch, K., & Hov, J. R. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102649 · Cited by 416
Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism
Haghikia, A., Zimmermann, F., Schumann, P., Jasina, A., Roessler, J., Schmidt, D., Heinze, P., Kaisler, J., Nageswaran, V., Aigner, A., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab644 · Cited by 376
TMAO: how gut microbiota contributes to heart failure
Zhang, Y., Wang, Y., Ke, B., & Du, J. (2020) · Translational research · doi:10.1016/j.trsl.2020.08.007 · Cited by 311
Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals
Zhang, X., Li, Y., Yang, P., Liu, X., Lu, L., Chen, Y., Zhong, X., Li, Z., Liu, H., Ou, C., et al. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313414 · Cited by 291
The gut microbiome and hypertension
O’Donnell, J. A., Zheng, T., Méric, G., & Marques, F. Z. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00654-0 · Cited by 302
Altered Gut Microbial Metabolites in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Signals in Host–Microbe Interplay
Wu, L., Han, Y., Zheng, Z., Peng, G., Liu, P., Yue, S., Zhu, S., Chen, J., Lv, H., Shao, L., et al. (2021) · Nutrients · doi:10.3390/nu13010228 · Cited by 227
Short-chain fatty acid, acylation and cardiovascular diseases
Chen, X., Chen, X., & Tang, X. (2020) · Clinical Science · doi:10.1042/cs20200128 · Cited by 189
Targeting the gut microbiota-related metabolites for osteoporosis: The inextricable connection of gut-bone axis
Zhang, Y., Wu, Y. Q., Liu, X.-F., Chen, X., & Su, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102196 · Cited by 157
Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome
Han, Q., Wang, J., Li, W., Chen, Z., & Du, Y. (2021) · Microbiome · doi:10.1186/s40168-021-01046-5 · Cited by 156
Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner
Carrillo-Salinas, F. J., Anastasiou, M., Ngwenyama, N., Kaur, K., Tai, A., Smolgovsky, S. A., Jetton, D., Aronovitz, M. J., & Alcaide, P. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1823801 · Cited by 146
Beneficial effect of the short-chain fatty acid propionate on vascular calcification through intestinal microbiota remodelling
Yan, J., Pan, Y., Shao, W., Wang, C., Wang, R., He, Y., Zhang, M., Wang, Y., Li, T., Wang, Z., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01390-0 · Cited by 150
Implication of Gut Microbiota in Cardiovascular Diseases
Zhou, W., Cheng, Y., Zhu, P., Nasser, M. I., Zhang, X., & Zhao, M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5394096 · Cited by 142
Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart
Carley, A. N., Maurya, S. K., Fasano, M. J., Wang, Y., Selzman, C. H., Drakos, S. G., & Lewandowski, E. D. (2021) · Circulation · doi:10.1161/circulationaha.120.052671 · Cited by 137
Microbial Peer Pressure
Muralitharan, R. R., Jama, H. A., Xie, L., Peh, A., Snelson, M., & Marques, F. Z. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14473 · Cited by 131
Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder
Luqman, A., Hassan, A., Ullah, M., Naseem, S., Ullah, M., Zhang, L., Din, A. U., Ullah, K., Ahmad, W., & Wang, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1321395 · Cited by 145
Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment
Yang, F., Chen, H., Gao, Y., An, N., Li, X., Pan, X., Yang, X., Tian, L., Sun, J., Xiong, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110503 · Cited by 135
Self-citation
Heart–gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion
Zhao, J., Qi, Z., Cheng, W., Dai, Q., Wei, Z., Guo, M., Chen, F., Qiao, S., Hu, J., Wang, J., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad023 · Cited by 126
Self-citation
Fecal g. Streptococcus and g. Eubacterium_coprostanoligenes_group combined with sphingosine to modulate the serum dyslipidemia in high-fat diet mice
Wei, W., Jiang, W., Tian, Z., Wu, H., Ning, H., Yan, G., Zhang, Z., Li, Z., Dong, F., Sun, Y., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.031 · Cited by 125
Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure
Jia, Q., Li, H., Zhou, H., Zhang, X., Zhang, A., Xie, Y., Li, Y., Lv, S., & Zhang, J. (2019) · Cardiovascular Therapeutics · doi:10.1155/2019/5164298 · Cited by 119
Gut microbiome mediates the protective effects of exercise after myocardial infarction
Zhou, Q., Deng, J., Pan, X., Meng, D., Zhu, Y., Bai, Y., Shi, C., Duan, Y., Wang, T., Li, X., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01271-6 · Cited by 110
Polyamine metabolism links gut microbiota and testicular dysfunction
Zhao, Q., Huang, J., Cheng, Y., Dai, M., Zhu, W., Yang, X., Gonzalez, F. J., & Li, F. (2021) · Microbiome · doi:10.1186/s40168-021-01157-z · Cited by 106
Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
Lu, Y., Zhang, Y., Zhao, X., Shang, C., Xiang, M., Li, L., & Cui, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.900381 · Cited by 120
Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review
Mamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 100
Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure
Snelson, M., Muralitharan, R. R., Liu, C., Markó, L., Forslund, S. K., Marques, F. Z., & Tang, W. H. W. (2025) · Circulation Research · doi:10.1161/circresaha.125.325516 · Cited by 118
Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
Chen, X., Zhang, H., Ren, S., Ding, Y.-N., Remex, N. S., Bhuiyan, M. S., Qu, J.-H., & Tang, X. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002206 · Cited by 101
Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD)
Hemmati, M., Kashanipoor, S., Mazaheri, P., Alibabaei, F., Babaeizad, A., Asli, S., Mohammadi, S., Gorgin, A. H., Ghods, K., Yousefi, B., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121947 · Cited by 105
Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes
Liao, C., Rolling, T., Djuković, A., Fei, T., Mishra, V., Liu, H., Lindberg, C., Dai, L., Zhai, B., Peled, J. U., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01680-3 · Cited by 98
Akkermansia muciniphila-derived acetate activates the hepatic AMPK/SIRT1/PGC-1α axis to alleviate ferroptosis in metabolic-associated fatty liver disease
Zhuge, A., Li, S., Han, S., Yuan, Y., Shen, J., Wu, W., Wang, K., Xia, J., Wang, Q., Gu, Y., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.010 · Cited by 97
Symbiotic Firmicutes establish mutualism with the host via innate tolerance and resistance to control systemic immunity
Jordan, C. K. I., Brown, R. L., Larkinson, M. L. Y., Sequeira, R. P., Edwards, A. M., & Clarke, T. B. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.07.008 · Cited by 90
Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment
Kappel, B. A., Angelis, L. D., Heiser, M., Ballanti, M., Stoehr, R., Goettsch, C., Mavilio, M., Artati, A., Paoluzi, O. A., Adamski, J., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.100976 · Cited by 92
Therapeutic and Improving Function of Lactobacilli in the Prevention and Treatment of Cardiovascular-Related Diseases: A Novel Perspective From Gut Microbiota
Zhao, X., Zhong, X., Liu, X., Wang, X., & Gao, X. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.693412 · Cited by 91
Gut-Derived Metabolite Indole-3-Propionic Acid Modulates Mitochondrial Function in Cardiomyocytes and Alters Cardiac Function
Gesper, M., Nonnast, A., Kumowski, N., Stoehr, R., Schuett, K. A., Marx, N., & Kappel, B. A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.648259 · Cited by 92
Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure
Chen, X., Li, H., Hu, X., Zhang, Y., & Zhang, S. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000330 · Cited by 84
Microbiota in Gut‐Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease
Kondapalli, N. B., Katari, V., Dalal, K. K., Paruchuri, S. M., & Thodeti, C. K. (2025) · Comprehensive physiology · doi:10.1002/cph4.70024 · Cited by 98
Yellow Wine Polyphenolic Compound Protects Against Doxorubicin-Induced Cardiotoxicity by Modulating the Composition and Metabolic Function of the Gut Microbiota
Lin, H., Meng, L., Sun, Z., Shiming, S., Huang, X., Lin, N., Zhang, J., Lu, W., Yang, Q., Chi, J., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.008220 · Cited by 84
Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment
Filippis, A. D., Ullah, H., Baldi, A., Dacrema, M., Esposito, C., Garzarella, E. U., Santarcangelo, C., Tantipongpiradet, A., & Daglia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144929 · Cited by 87
Gut microbiota and microbial metabolites for osteoporosis
Zheng, X.-Q., Wang, D.-B., Jiang, Y., & Song, C. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2437247 · Cited by 91
Thyroid hormone receptor-beta agonist HSK31679 alleviates MASLD by modulating gut microbial sphingolipids
Zhang, Y., Xie, R., Dai, C.-S., Gao, H., Zhou, G., Qi, T., Wang, W.-Y., Wang, H., & Yi-min, C. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.008 · Cited by 77
Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases
Bai, X., Wang, W.-X., Fu, R., Yue, S., Gao, H., Chen, Y., & Tang, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01265 · Cited by 75
Gut butyrate-producers confer post-infarction cardiac protection
Chen, H.-C., Liu, Y.-W., Chang, K., Wu, Y., Chen, Y., Chao, Y.-K., You, M.-Y., Lundy, D. J., Lin, C., Hsieh, M. L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43167-5 · Cited by 81
Self-citation
Role of the microbiota–gut–heart axis between bile acids and cardiovascular disease
Zhang, Z., Lv, T., Wang, X., Wu, M., Zhang, R., Yang, X., Fu, Y., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116567 · Cited by 79
Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction
Zhao, W., Zhao, J., & Rong, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8815349 · Cited by 78
Adding insult to injury - Inflammation at the heart of cardiac fibrosis
Smolgovsky, S. A., Ibeh, U., Tamayo, T. P., & Alcaide, P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109828 · Cited by 71
Remodeling of the gut microbiome by Lactobacillus johnsonii alleviates the development of acute myocardial infarction
Zhong, X., Zhao, Y., Huang, L. J., Liu, J., Wang, K., Gao, X., Zhao, X., & Wang, X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1140498 · Cited by 66
Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis
Luo, P., Lednovich, K., Xu, K., Nnyamah, C., Layden, B. T., & Xu, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.003 · Cited by 62
Alterations in gut microbiota and metabolites associated with altitude-induced cardiac hypertrophy in rats during hypobaric hypoxia challenge
Pan, Z., Hu, Y., Huang, Z., Han, N., Li, Y., Zhuang, X., Yin, J., Peng, H., Gao, Q., Zhang, W., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2056-1 · Cited by 64
Gut microbiota protects from triptolide-induced hepatotoxicity: Key role of propionate and its downstream signalling events
Huang, J., Zhao, Q., Dai, M., Xiao, X.-R., Zhang, T., Zhu, W., & Li, F. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104752 · Cited by 63
Short-Chain Fatty Acids in the Metabolism of Heart Failure – Rethinking the Fat Stigma
Palm, C. L., Nijholt, K. T., Bakker, B. M., & Westenbrink, B. D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.915102 · Cited by 64
Melatonin alleviates Ochratoxin A-induced liver inflammation involved intestinal microbiota homeostasis and microbiota-independent manner
Xia, D., Yang, L., Li, Y., Chen, J., Zhang, X., Wang, H., Zhai, S., Jiang, X., Meca, G., Wang, S., et al. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.125239 · Cited by 60
The emerging role of gut microbial metabolism on cardiovascular disease
Kasahara, K., & Rey, F. E. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.09.007 · Cited by 59
Self-citation
Oral Supplementation With Butyrate Improves Myocardial Ischemia/Reperfusion Injury via a Gut-Brain Neural Circuit
Yu, Z., Han, J., Chen, H., Wang, Y., Zhou, L., Wang, M., Zhang, R., Jin, X., Zhang, G., Wang, C., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.718674 · Cited by 59
Self-citation
Update on gut microbiota in cardiovascular diseases
Qian, B., Zhang, K., Li, Y., & Sun, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1059349 · Cited by 63
Opportunities and challenges of bacterial extracellular vesicles in regenerative medicine
Guo, J., Huang, Z., Wang, Q., Wang, M., Ming, Y., Chen, W., Huang, Y., Tang, Z., Huang, M., Liu, H., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02935-1 · Cited by 66
Anti-hypertensive and cardioprotective activities of traditional Chinese medicine-derived polysaccharides: A review
Xie, M., Tao, W., Wu, F., Wu, K., Huang, X., Ling, G., Zhao, C., Lv, Q., Wang, Q., Zhou, X., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.07.008 · Cited by 56
Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases
Xu, J., & Yang, Y. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1936379 · Cited by 61
Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity
Čierniková, S., Mego, M., & Chovanec, M. (2021) · Cancers · doi:10.3390/cancers13040782 · Cited by 55
Oral-gut microbial transmission promotes diabetic coronary heart disease
Li, Y., Liu, Y., Cui, J., Zhu, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02217-y · Cited by 53
Gut microbiota regulates cardiac ischemic tolerance and aortic stiffness in obesity
Battson, M. L., Lee, D. M., Puma, L. C. L., Ecton, K. E., Thomas, K. N., Febvre, H. P., Chicco, A. J., Weir, T. L., & Gentile, C. L. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00346.2019 · Cited by 51
Hypotension as a marker or mediator of perioperative organ injury: a narrative review
Ackland, G. L., & Abbott, T. E. F. (2022) · British Journal of Anaesthesia · doi:10.1016/j.bja.2022.01.012 · Cited by 53
Exercise ameliorates osteopenia in mice via intestinal microbial-mediated bile acid metabolism pathway
Yu, C., Sun, R., Yang, W., Gu, T., Ying, X., Ye, L., Zheng, Y., Fan, S., Zeng, X., & Yao, S. (2025) · Theranostics · doi:10.7150/thno.104186 · Cited by 52
Antibiotic-induced gut microbiota depletion exacerbates host hypercholesterolemia
Kappel, B. A., Angelis, L. D., Puetz, A., Ballanti, M., Menghini, R., Marx, N., & Federici, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106570 · Cited by 49
The Gut–Heart Axis: Molecular Perspectives and Implications for Myocardial Infarction
Rivera, K., González, L., Bravo, L., Manjarres, L., & Andía, M. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212465 · Cited by 51
Gut Microbiome-Based Management of Patients With Heart Failure
Mamic, P., Snyder, M. P., & Tang, W. H. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.02.045 · Cited by 51
Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice
Yang, N., Lan, T., Han, Y., Zhao, H., Wang, C., Xu, Z. C., Zhao, C., Tao, M., Li, H., Song, Y., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289364 · Cited by 50
Prophylactic Supplementation with Lactobacillus Reuteri or Its Metabolite GABA Protects Against Acute Ischemic Cardiac Injury
Wang, J., Zhang, H., Yuan, H., Chen, S., Yu, Y., Zhang, X., Gao, Z., Du, H., Li, W., Wang, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202307233 · Cited by 43
Development of an Efficient and Sensitive Chemical Derivatization-Based LC–MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular Disease
Liao, H.-Y., Wang, C., Lee, C.-H., Kao, H., Wu, W., & Kuo, C. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00147 · Cited by 43
Self-citation
Intermingling of gut microbiota with brain: Exploring the role of probiotics in battle against depressive disorders
Tyagi, P., Tasleem, M., Prakash, S., & Chouhan, G. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109489 · Cited by 42
Propionate Alleviates Abdominal Aortic Aneurysm by Modulating Colonic Regulatory T-Cell Expansion and Recirculation
Yang, F., Xia, N., Guo, S., Zhang, J., Liao, Y., Tang, T., Nie, S., Zhang, M., Lv, B., Lu, Y., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.05.001 · Cited by 44
Self-citation
The gut–immune axis during hypertension and cardiovascular diseases
Dinakis, E., O’Donnell, J. A., & Marques, F. Z. (2024) · Acta Physiologica · doi:10.1111/apha.14193 · Cited by 49
Gut and Cutaneous Microbiome Featuring Abundance of Lactobacillus reuteri Protected Against Psoriasis-Like Inflammation in Mice
Chen, H., Zeng, Y.-B., Zhang, Z., Kong, C., Zhang, S., Li, Z., Huang, J., Xu, Y., Mao, Y., Cai, P., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s337031 · Cited by 41
Self-citation
Commensal gut microbiota-derived acetate and propionate enhance heart adaptation in response to cardiac pressure overload in mice
Lin, C., Cheng, Y., Chen, H.-C., Chao, Y.-K., Nicholson, M. W., Yen, C.-L., Kamp, T. J., & Hsieh, P. C. H. (2022) · Theranostics · doi:10.7150/thno.76002 · Cited by 42
Self-citation
Gut Microbiota Involvement in Ventricular Remodeling Post–Myocardial Infarction
McMillan, A., & Hazen, S. L. (2019) · Circulation · doi:10.1161/circulationaha.118.037384 · Cited by 39
Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids
Li, Q., Gao, B. X., Bateer, S., He, Q., Zhang, R., Meng, X., Naiheng, Z., Li, M., & Li, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.651926 · Cited by 40
The short-chain fatty acid propionate improved ventricular electrical remodeling in a rat model with myocardial infarction
Zhou, M., Li, D., Xie, K., Xu, L., Kong, B., Wang, X., Tang, Y., Liu, Y., & Huang, H. (2021) · Food & Function · doi:10.1039/d1fo02040d · Cited by 39
Endocrine organs of cardiovascular diseases: Gut microbiota
Jia, Q., Xie, Y., Lu, C., Zhang, A., Lu, Y., Lv, S., & Zhang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14164 · Cited by 38
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
Liu, Y., Yang, H., Li, T. X., & Zhang, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1460282 · Cited by 39
Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocardial function
Steffens, S., Linthout, S. V., Sluijter, J. P. G., Tocchetti, C. G., Thum, T., & Madonna, R. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa137 · Cited by 38
Circadian influence on the microbiome improves heart failure outcomes
Mistry, P., Reitz, C. J., Khatua, T. N., Rasouli, M., Oliphant, K., Young, M. E., Allen‐Vercoe, E., & Martino, T. A. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.09.006 · Cited by 38
Inflammatory Response: A Crucial Way for Gut Microbes to Regulate Cardiovascular Diseases
Wang, W., Zhu, L., Leng, Y.-Q., Wang, Y.-W., Shi, T., Wang, W., & Sun, J. (2023) · Nutrients · doi:10.3390/nu15030607 · Cited by 35
Intrinsic and Extrinsic Contributors to the Cardiac Benefits of Exercise
Hastings, M. H., Castro, C., Freeman, R., Kadir, A. A., Lerchenmüller, C., Li, H., Rhee, J., Roh, J. D., Roh, K., Singh, A. P., et al. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.07.011 · Cited by 36
The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure
Sata, Y., Marques, F. Z., & Kaye, D. M. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01046-0 · Cited by 34
Gastrodin attenuates perfluorooctanoic acid-induced liver injury by regulating gut microbiota composition in mice
Ma, S., Sun, Y., Zheng, X., & Yang, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.2009966 · Cited by 35
Gut Microbiome-Targeted Modulations Regulate Metabolic Profiles and Alleviate Altitude-Related Cardiac Hypertrophy in Rats
Hu, Y., Pan, Z., Huang, Z., Li, Y., Han, N., Zhuang, X., Peng, H., Gao, Q., Wang, Q., Lee, B. J. Y., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01053-21 · Cited by 36
Short-Chain Carbon Sources
Challa, A. A., & Lewandowski, E. D. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.12.010 · Cited by 35
Gut microbiota and healthy longevity
Luo, J., Liang, S., & Jin, F. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2595-5 · Cited by 37
Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis
Yeh, C., Chen, Y.-H., Liu, S.-F., Kao, H., Wu, M., Yang, K., & Wu, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228729 · Cited by 37
The Gut in Heart Failure: Current Knowledge and Novel Frontiers
Gallo, A., Macerola, N., Favuzzi, A. M. R., Nicolazzi, M. A., Gasbarrini, A., & Montalto, M. (2022) · Medical Principles and Practice · doi:10.1159/000522284 · Cited by 36
Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis
Yang, L., Wang, T., Zhang, X., Zhang, H., Yan, N., Zhang, G., Yan, R., Li, Y., Yu, J., He, J., et al. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02508-w · Cited by 34
Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus
Sanchez‐Quintero, M. J., Delgado, J., Vera, D. M., Becerra‐Muñoz, V. M., Queipo‐Ortuño, M. I., Estévez, M., Plaza-Andrades, I. J., Rodríguez‐Capitán, J., Sanchez, P. L., Crespo-Leiro, M. G., et al. (2022) · Nutrients · doi:10.3390/nu14214650 · Cited by 38
Gut microbiota and myocardial fibrosis
Han, X., Yang, F., & Bao, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175355 · Cited by 35
Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach—A Comprehensive Narrative Review
Uceda, S., Echeverry‐Alzate, V., Reiriz, M., Miguel, E. M., Pérez-Curiel, A., Gómez-Senent, S., & Beltrán-Velasco, A. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713294 · Cited by 36
Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions
Huang, C., Li, X., Li, H., Chen, R., Li, Z., Li, D., Xu, X., Zhang, G., Qin, L., Li, B., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05232-5 · Cited by 36
GV-971 prevents severe acute pancreatitis by remodeling the microbiota-metabolic-immune axis
Chen, X., Chen, X., Ding, Y. P., Zhang, N., Fu, W., Wu, M., Ge, F., Wang, J., Li, X., Geng, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52398-z · Cited by 33
Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases
Chen, N., Chan, C. K., Khan, F. U., Makhijani, P., Valentino, T. R., Winer, S., Luk, C. T., & Winer, D. A. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103036 · Cited by 37
Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights
Song, Y., Wei, H., Zhou, Z., Wang, H., Hang, W., Wu, J., & Wang, D. W. (2024) · Frontiers of Medicine · doi:10.1007/s11684-024-1055-9 · Cited by 38
Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischaemic heart disease
Pham, Q. H., Bui, T. V. A., Sim, W., Lim, K. H., Law, C. O. K., Tan, W., Kim, R. Y., Chow, K. T., Park, H., Ban, K., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae128 · Cited by 32

Authors: Tang, T. W. H., Chen, H.-C., Chen, C.-Y., Yen, C. Y. T., Lin, C.-J., Prajnamitra, R. P., Chen, L.-L., Ruan, S.-C., Lin, J.-H., Lin, P.-J., Lu, H.-H., Kuo, C.-W., Chang, C. M., Hall, A. D., Vivas, E. I., Shui, J.-W., Chen, P., Hacker, T. A., Rey, F. E., Kamp, T. J., & Hsieh, P. C. H.
Affiliations: Institute of Biomedical Sciences, Academia Sinica (TW)
Research Center for Applied Science, Academia Sinica (TW)
University of Wisconsin–Madison (US)
ORCID: Chen, Hung-Chih
Yen, Christopher Y.T.
Lin, Chen-Ju
Prajnamitra, Ray P.
Chen, Li-Lun
Ruan, Shu-Chian
Lu, Hsueh-Han
Chang, Cindy M.
Shui, Jr-Wen
Chen, Peilin
Hacker, Timothy A.
Rey, Federico E.
Kamp, Timothy J.
Hsieh, Patrick C.H.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2019-01-29
Volume: 139
Issue: 5
Pages: 647-659
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.118.035235
OpenAlex: W2896600834
Cited by: 348
References: 43
Citations by year: 2026: 29 · 2025: 56 · 2024: 67 · 2023: 51 · 2022: 46 · 2021: 57 · 2020: 32 · 2019: 10
FWCI: 12.00
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords: gut microbiota, myocardial infarction, cardiac repair, short-chain fatty acids, myeloid cells, Lactobacillus, probiotics, antibiotic depletion, fecal microbiota transplantation, cardioprotection
MeSH terms: RAW 264.7 Cells, Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Anti-Bacterial Agents, Bacteria, Disease Models, Animal, Fatty Acids, Female, Lactobacillus, Male, Mice, Inbred C57BL, Mice, Transgenic, Monocytes, Myocardial Infarction, Myocardium, Probiotics, Mice, Host-Pathogen Interactions, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks